Product Description
| Brand | Snibe |
| Sample Type | Serum |
| Pack Size | 100T |
| CAT No. | 130210023M |
| Application | Infectious Disease |
The kit has been designed for the qualitative determination of antibodies to Hepatitis B core antigen (anti-HBc) in human serum or plasma. The method can be used for samples within a measuring range of 0.110 COI. The test is performed on fully automated MAGLUMI chemiluminescence immunoassay (CLIA) analyzers, including MAGLUMI 800, MAGLUMI X8, and other MAGLUMI models such as MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, and MAGLUMI 4000.Advanced Technology for Reliable DiagnosisThe MAGLUMI anti-HBc (CLIA) reagent utilizes advanced chemiluminescence immunoassay technology to deliver precise and dependable results for hepatitis B core antibody detection. Optimized for MAGLUMI analyzers, this reagent enhances laboratory workflow with automated, real-time processing.
Optimal Storage and HandlingTo ensure the integrity and efficacy of the MAGLUMI anti-HBc (CLIA) reagent, it must be stored between 2 and 8C. Following these storage instructions is vital for maintaining longevity and test accuracy, making it well-suited for centralized laboratories.
FAQ's of MAGLUMI anti-HBc (CLIA):
Q: How is the MAGLUMI anti-HBc (CLIA) reagent used in the laboratory?
A: The reagent is designed for use with MAGLUMI CLIA analyzers to detect hepatitis B core antibodies in human serum or plasma samples, supporting the diagnosis of hepatitis B infection through a chemiluminescence immunoassay process.
Q: What are the storage requirements for this reagent kit?
A: The MAGLUMI anti-HBc (CLIA) must be stored at a temperature between 2 and 8 degrees Celsius to preserve its stability and ensure reliable results throughout its shelf life.
Q: When should laboratories use the anti-HBc (CLIA) reagent?
A: Laboratories should use this reagent when there is a need to screen or confirm hepatitis B core antibody presence in patient samples, either as part of routine diagnostic assessments or detailed infectious disease panels.
Q: Where can the MAGLUMI anti-HBc (CLIA) reagent be sourced in India?
A: This reagent is available through authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India, ensuring broad accessibility for clinical laboratories.
Q: What benefits does using chemiluminescence immunoassay technology provide?
A: Chemiluminescence immunoassay technology offers heightened sensitivity and specificity, rapid processing, and automated workflows, which collectively enhance laboratory efficiency and diagnostic confidence.
Q: How does real-time operation improve laboratory workflow?
A: Real-time operation allows the MAGLUMI anti-HBc (CLIA) system to deliver immediate results with minimal manual intervention, reducing turnaround time and supporting prompt clinical decision-making.